Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia

Saved in:
Bibliographic Details
Published inClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology Vol. 19; no. 4; pp. 600 - 609
Main Authors Jung-Jin Kim, Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand
Format Journal Article
LanguageKorean
Published KOREAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY 30.11.2021
대한정신약물학회
Subjects
Antipsychotics
Polypharmacy
Issue
Schizophrenia
Online AccessGet full text

Cover

Table of Contents:
  • INTRODUCTION WHEN AND HOW TO INITIATE APP? TOTAL NUMBER OF APP OR TOTAL DAILY DOSE OF APP, WHICH IS MORE PROBLEMATIC? IS INSIGHT ONE OF ISSUES IN THE USE OF APP? IS THERE ANY BEST-AVAILABLE APP REGIMEN FOR TREATMENT OF SCHIZOPHRENIA? HOW TO SWITCH APP TO APM IN CLINICAL PRACTICE? DISCUSSION